HEADER TRANSFERASE 16-MAR-05 1Z4U TITLE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH TITLE 2 INHIBITOR PHA-00799585 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HCV NS5B POLYMERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.7.48; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_TAXID: 11103; SOURCE 4 STRAIN: J1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NS5B, POLYMERASE, HCV, FINGERS, PALM, THUMB, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.A.PFEFFERKORN,M.GREENE,R.NUGENT,R.J.GROSS,M.A.MITCHELL,B.C.FINZEL, AUTHOR 2 M.S.HARRIS,P.A.WELLS,J.A.SHELLY,R.ANSTADT REVDAT 4 11-OCT-17 1Z4U 1 REMARK REVDAT 3 13-JUL-11 1Z4U 1 VERSN REVDAT 2 24-FEB-09 1Z4U 1 VERSN REVDAT 1 07-JUN-05 1Z4U 0 JRNL AUTH J.A.PFEFFERKORN,R.NUGENT,R.J.GROSS,M.GREENE,M.A.MITCHELL, JRNL AUTH 2 M.T.REDING,L.A.FUNK,R.ANDERSON,P.A.WELLS,J.A.SHELLY, JRNL AUTH 3 R.ANSTADT,B.C.FINZEL,M.S.HARRIS,R.E.KILKUSKIE,L.A.KOPTA, JRNL AUTH 4 F.J.SCHWENDE JRNL TITL INHIBITORS OF HCV NS5B POLYMERASE. PART 2: EVALUATION OF THE JRNL TITL 2 NORTHERN REGION OF JRNL TITL 3 (2Z)-2-BENZOYLAMINO-3-(4-PHENOXY-PHENYL)-ACRYLIC ACID JRNL REF BIOORG.MED.CHEM.LETT. V. 15 2812 2005 JRNL REFN ISSN 0960-894X JRNL PMID 15911260 JRNL DOI 10.1016/J.BMCL.2005.03.106 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.A.PFEFFERKORN,M.L.GREENE,R.A.NUGENT,R.J.GROSS, REMARK 1 AUTH 2 M.A.MITCHELL,B.C.FINZEL,M.S.HARRIS,P.A.WELLS,J.A.SHELLY, REMARK 1 AUTH 3 R.A.ANSTADT REMARK 1 TITL INHIBITORS OF HCV NS5B POLYMERASE: PART 1: EVALUATION OF THE REMARK 1 TITL 2 SOUTHERN REGION OF REMARK 1 TITL 3 (2Z)-2-(BENZOYLAMINO)-3-(5-PHENYL-2-FURYL)ACRYLIC ACID REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 15 2481 2005 REMARK 1 REFN ISSN 0960-894X REMARK 1 DOI 10.1016/J.BMCL.2005.03.066 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.8 REMARK 3 NUMBER OF REFLECTIONS : 20477 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : CCP4 UNIQUEIFY 5% REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1100 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4390 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 158 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Z4U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAR-05. REMARK 100 THE DEPOSITION ID IS D_1000032299. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-NOV-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23010 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.47100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1YVF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 126.07400 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 63.03700 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 63.03700 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 126.07400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 43830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 126.07400 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CL CL A 701 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 564 REMARK 465 SER A 565 REMARK 465 ARG A 566 REMARK 465 ALA A 567 REMARK 465 ARG A 568 REMARK 465 PRO A 569 REMARK 465 ARG A 570 REMARK 465 HIS A 571 REMARK 465 HIS A 572 REMARK 465 HIS A 573 REMARK 465 HIS A 574 REMARK 465 HIS A 575 REMARK 465 HIS A 576 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 15 -153.82 -108.45 REMARK 500 ILE A 23 32.14 119.18 REMARK 500 HIS A 34 12.47 -61.40 REMARK 500 SER A 42 3.31 -62.87 REMARK 500 SER A 76 13.84 -61.95 REMARK 500 PHE A 101 54.14 -106.37 REMARK 500 LEU A 111 27.34 44.46 REMARK 500 SER A 112 156.31 -48.58 REMARK 500 ASP A 131 -36.25 -138.57 REMARK 500 THR A 181 -39.53 -141.26 REMARK 500 CYS A 223 68.19 36.92 REMARK 500 GLN A 241 -15.63 -46.88 REMARK 500 VAL A 262 2.33 -69.50 REMARK 500 ASP A 310 75.96 33.52 REMARK 500 ALA A 348 53.76 -162.59 REMARK 500 SER A 367 18.66 59.26 REMARK 500 SER A 377 32.04 -79.50 REMARK 500 GLN A 436 -1.00 -148.20 REMARK 500 GLU A 437 73.50 46.31 REMARK 500 LEU A 457 -2.44 -57.32 REMARK 500 ALA A 471 -5.00 -54.58 REMARK 500 LEU A 497 -34.31 -39.40 REMARK 500 SER A 506 -70.24 -59.01 REMARK 500 GLN A 514 -7.35 -158.70 REMARK 500 THR A 532 98.30 -66.68 REMARK 500 ARG A 544 44.33 -71.03 REMARK 500 SER A 548 -74.74 -40.58 REMARK 500 TRP A 550 -85.11 -41.71 REMARK 500 VAL A 552 -48.39 -130.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PH9 A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 605 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YVF RELATED DB: PDB REMARK 900 HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH REMARK 900 INHIBITOR PHA-00799585 DBREF 1Z4U A 1 570 UNP O93077 O93077_9HEPC 2420 2989 SEQRES 1 A 577 MET SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR SEQRES 2 A 577 PRO CYS ALA ALA GLU GLU SER LYS LEU PRO ILE ASN ALA SEQRES 3 A 577 LEU SER ASN SER LEU LEU ARG HIS HIS ASN LEU VAL TYR SEQRES 4 A 577 SER THR THR SER ARG SER ALA SER LEU ARG GLN LYS LYS SEQRES 5 A 577 VAL THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR SEQRES 6 A 577 ARG ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR SEQRES 7 A 577 VAL LYS ALA LYS LEU LEU SER VAL GLU GLU ALA CYS LYS SEQRES 8 A 577 LEU THR PRO PRO HIS SER ALA LYS SER LYS PHE GLY TYR SEQRES 9 A 577 GLY ALA LYS ASP VAL ARG SER LEU SER SER ARG ALA VAL SEQRES 10 A 577 ASN HIS ILE ARG SER VAL TRP LYS ASP LEU LEU GLU ASP SEQRES 11 A 577 THR ASP THR PRO ILE GLN THR THR ILE MET ALA LYS ASN SEQRES 12 A 577 GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS SEQRES 13 A 577 PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG SEQRES 14 A 577 VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR SEQRES 15 A 577 LEU PRO GLN ALA VAL MET GLY SER SER TYR GLY PHE GLN SEQRES 16 A 577 TYR SER PRO LYS GLN ARG VAL GLU PHE LEU VAL ASN THR SEQRES 17 A 577 TRP LYS ALA LYS LYS CYS PRO MET GLY PHE SER TYR ASP SEQRES 18 A 577 THR ARG CYS PHE ASP SER THR VAL THR GLU ASN ASP ILE SEQRES 19 A 577 ARG VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA SEQRES 20 A 577 PRO GLU ALA ARG GLN ALA ILE ARG SER LEU THR GLU ARG SEQRES 21 A 577 LEU TYR VAL GLY GLY PRO MET THR ASN SER LYS GLY GLN SEQRES 22 A 577 ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU SEQRES 23 A 577 THR THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS SEQRES 24 A 577 ALA ALA ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS SEQRES 25 A 577 THR MET LEU VAL ASN GLY ASP ASP LEU VAL VAL ILE CYS SEQRES 26 A 577 GLU SER ALA GLY THR GLN GLU ASP ALA ALA SER LEU ARG SEQRES 27 A 577 VAL PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO SEQRES 28 A 577 GLY ASP PRO PRO GLN PRO GLU TYR ASP LEU GLU LEU ILE SEQRES 29 A 577 THR SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA SEQRES 30 A 577 SER GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR SEQRES 31 A 577 VAL PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS SEQRES 32 A 577 THR PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET TYR SEQRES 33 A 577 ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS SEQRES 34 A 577 PHE PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS SEQRES 35 A 577 ALA LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE SEQRES 36 A 577 GLU PRO LEU ASP LEU PRO GLN ILE ILE GLU ARG LEU HIS SEQRES 37 A 577 GLY LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY SEQRES 38 A 577 GLU ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY SEQRES 39 A 577 VAL PRO PRO LEU ARG VAL TRP ARG HIS ARG ALA ARG SER SEQRES 40 A 577 VAL ARG ALA LYS LEU LEU SER GLN GLY GLY ARG ALA ALA SEQRES 41 A 577 ILE CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL ARG THR SEQRES 42 A 577 LYS LEU LYS LEU THR PRO ILE PRO ALA ALA SER ARG LEU SEQRES 43 A 577 LEU LEU SER GLY TRP PHE VAL ALA GLY TYR SER GLY GLY SEQRES 44 A 577 ASP ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG HIS SEQRES 45 A 577 HIS HIS HIS HIS HIS HET CL A 701 1 HET PO4 A 702 5 HET PH9 A 600 32 HET GOL A 602 6 HET GOL A 604 6 HET GOL A 605 6 HETNAM CL CHLORIDE ION HETNAM PO4 PHOSPHATE ION HETNAM PH9 (2Z)-2-[(1-ADAMANTYLCARBONYL)AMINO]-3-[4-(2- HETNAM 2 PH9 BROMOPHENOXY)PHENYL]PROP-2-ENOIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 CL CL 1- FORMUL 3 PO4 O4 P 3- FORMUL 4 PH9 C26 H28 BR N O4 FORMUL 5 GOL 3(C3 H8 O3) FORMUL 8 HOH *158(H2 O) HELIX 1 1 LEU A 26 LEU A 30 5 5 HELIX 2 2 SER A 44 THR A 53 1 10 HELIX 3 3 ASP A 61 SER A 76 1 16 HELIX 4 4 SER A 84 LYS A 90 1 7 HELIX 5 5 GLY A 104 SER A 110 1 7 HELIX 6 6 SER A 112 ASP A 129 1 18 HELIX 7 7 GLN A 148 GLY A 152 5 5 HELIX 8 8 ASP A 164 TYR A 176 1 13 HELIX 9 9 THR A 181 GLY A 188 1 8 HELIX 10 10 SER A 189 TYR A 195 5 7 HELIX 11 11 SER A 196 ALA A 210 1 15 HELIX 12 12 CYS A 223 VAL A 228 1 6 HELIX 13 13 THR A 229 GLN A 241 1 13 HELIX 14 14 ALA A 246 LEU A 260 1 15 HELIX 15 15 THR A 286 LYS A 307 1 22 HELIX 16 16 GLY A 328 TYR A 346 1 19 HELIX 17 17 ASP A 359 ILE A 363 5 5 HELIX 18 18 PRO A 388 ARG A 401 1 14 HELIX 19 19 ASN A 406 TYR A 415 1 10 HELIX 20 20 THR A 418 ILE A 424 1 7 HELIX 21 21 ILE A 424 LEU A 433 1 10 HELIX 22 22 GLU A 455 LEU A 457 5 3 HELIX 23 23 ASP A 458 GLY A 468 1 11 HELIX 24 24 LEU A 469 SER A 473 5 5 HELIX 25 25 SER A 478 GLY A 493 1 16 HELIX 26 26 PRO A 496 SER A 513 1 18 HELIX 27 27 ARG A 517 LEU A 525 1 9 HELIX 28 28 ILE A 539 SER A 543 5 5 SHEET 1 A 2 SER A 1 MET A 2 0 SHEET 2 A 2 ASP A 55 ARG A 56 -1 O ARG A 56 N SER A 1 SHEET 1 B 5 TYR A 4 TRP A 6 0 SHEET 2 B 5 ASN A 273 ARG A 277 -1 O TYR A 276 N THR A 5 SHEET 3 B 5 GLY A 264 THR A 267 -1 N MET A 266 O CYS A 274 SHEET 4 B 5 THR A 136 ALA A 140 1 N ILE A 138 O THR A 267 SHEET 5 B 5 LEU A 159 PHE A 162 -1 O ILE A 160 N MET A 139 SHEET 1 C 2 VAL A 37 SER A 39 0 SHEET 2 C 2 VAL A 144 CYS A 146 -1 O PHE A 145 N TYR A 38 SHEET 1 D 3 PRO A 214 TYR A 219 0 SHEET 2 D 3 ASP A 319 GLU A 325 -1 O VAL A 322 N PHE A 217 SHEET 3 D 3 GLN A 309 ASN A 316 -1 N THR A 312 O ILE A 323 SHEET 1 E 2 ASN A 369 HIS A 374 0 SHEET 2 E 2 ARG A 380 THR A 385 -1 O VAL A 381 N ALA A 373 SHEET 1 F 2 LEU A 443 ILE A 447 0 SHEET 2 F 2 ALA A 450 ILE A 454 -1 O ILE A 454 N LEU A 443 SITE 1 AC1 1 GLY A 480 SITE 1 AC2 4 GLY A 480 ARG A 484 HOH A 708 HOH A 709 SITE 1 AC3 18 ARG A 200 ASN A 316 CYS A 366 SER A 368 SITE 2 AC3 18 LEU A 384 GLY A 410 ASN A 411 MET A 414 SITE 3 AC3 18 TYR A 415 GLN A 446 ILE A 447 TYR A 448 SITE 4 AC3 18 SER A 556 GOL A 602 HOH A 704 HOH A 706 SITE 5 AC3 18 HOH A 749 HOH A 767 SITE 1 AC4 6 ASP A 319 CYS A 366 SER A 367 PH9 A 600 SITE 2 AC4 6 HOH A 749 HOH A 762 SITE 1 AC5 6 CYS A 213 THR A 329 TYR A 358 GOL A 605 SITE 2 AC5 6 HOH A 818 HOH A 826 SITE 1 AC6 6 ASP A 359 LEU A 419 ILE A 482 LEU A 497 SITE 2 AC6 6 GOL A 604 HOH A 806 CRYST1 91.344 91.344 189.111 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010948 0.006321 0.000000 0.00000 SCALE2 0.000000 0.012641 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005288 0.00000 MASTER 346 0 6 28 16 0 13 6 0 0 0 45 END